Oral enoximone allows the reduction and discontinuation of inhaled steroids and beta2 agonists in asthmatic children
{{output}}
In the last two decades, improvement on asthma treatment has been merely marginal for both adults and children; inhaled corticosteroids (ICS) combined with β-2-mimetics remain the main therapy [3,4]. "New" therapies are just variations on ICS or, for children... ...
